Tower Research Capital LLC (Trc) Galapagos Nv Transaction History
Tower Research Capital LLC (Trc)
- $4.87 Billion
- Q4 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Galapagos Nv stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 830 shares of GLPG stock, worth $22,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
830
Previous 357
132.49%
Holding current value
$22,152
Previous $10,000
120.0%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding GLPG
# of Institutions
90Shares Held
13.2MCall Options Held
213KPut Options Held
126K-
Tang Capital Management LLC San Diego, CA2.16MShares$57.7 Million4.46% of portfolio
-
Bvf Inc San Francisco, CA1.57MShares$41.9 Million1.62% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY1.41MShares$37.7 Million0.96% of portfolio
-
Prosight Management, LP Dallas, TX1.03MShares$27.4 Million8.37% of portfolio
-
Deep Track Capital, LP Greenwich, CT781KShares$20.8 Million0.95% of portfolio
About GALAPAGOS NV
- Ticker GLPG
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,835,500
- Market Cap $1.76B
- Description
- Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...